MIMagnus Isaksson

Magnus Isaksson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Magnus Isaksson has a total of 147 co-authors. Here are the top co-authors by number of shared publications:

  • Aaron Harding

    Sharp HealthCare, San Diego, USA

    1 shared publication
  • Abbas Hakim

    Expedited COVID Identification Environment (EXCITE) Laboratory, Department of Pediatrics, University of California San Diego, La Jolla, USA

    1 shared publication
  • Adam M. Mark

    Center for Computational Biology and Bioinformatics, University of California San Diego, La Jolla, USA

    1 shared publication
  • Alexander T. Yu

    COVID-19 Detection, Investigation, Surveillance, Clinical, and Outbreak Response, California Department of Public Health, Richmond, USA

    1 shared publication
  • Alexandre Bolze

    McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center 4 , Dallas, TX

    1 shared publication
  • Alison Sanders

    Return to Learn, University of California San Diego, La Jolla, USA

    1 shared publication

Latest Publications

  • Top Cited Papers
    Open Access

    Wastewater sequencing reveals early cryptic SARS-CoV-2 variant transmission

    by Smruthi Karthikeyan, Joshua I. Levy, Peter De Hoff, Greg Humphrey, Amanda Birmingham, Kristen Jepsen, Sawyer Farmer, Helena M. Tubb, Tommy Valles, Caitlin E. Tribelhorn, et al.

    As SARS-CoV-2 continues to spread and evolve, detecting emerging variants early is critical for public health interventions. Inferring lineage prevalence by clinical testing is infeasible at scale, especially in areas with limited resources, participation, or testing and/or sequencing capacity, which can also introduce biases1–3. SARS-CoV-2 RNA concentration in wastewater successfully tracks regional infection dynamics and provides less biased abundance estimates than clinical testing4,5. Tracking virus genomic sequences in wastewater would improve community prevalence estimates and detect emerging variants. However, two factors limit wastewater-based genomic surveillance: low-quality sequence data and inability to estimate relative lineage abundance in mixed samples. Here we resolve these critical issues to perform a high-resolution, 295-day wastewater and clinical sequencing effort, in the controlled environment of a large university campus and the broader context of the surrounding county. We developed and deployed improved virus concentration protocols and deconvolution software that fully resolve multiple virus strains from wastewater. We detected emerging variants of concern up to 14 days earlier in wastewater samples, and identified multiple instances of virus spread not captured by clinical genomic surveillance. Our study provides a scalable solution for wastewater genomic surveillance that allows early detection of SARS-CoV-2 variants and identification of cryptic transmission.


  • Open Access

    Robots are a Promising Investment to Fight Pandemics

    by Rabe Andersson, Niclas Bjorsell, Magnus Isaksson

    Coronavirus caused pandemics as many viruses did through human history. The current pandemic causes overwhelmed healthcare system, locked down cities, and massive fatality among humans. Thus, different robots have been used since the COVID outbreak worldwide to reduce spreading infectious diseases and support frontline healthcare workers. This paper sets out the different robots implemented for hospital, non-hospital use, and possible use that can be deployed amidst the pandemic. A literature survey of versatile robots during COVID-19 is introduced. Roboticists contributed with wheeled and drone robots with various applications to assist medical care systems and society during the ongoing crisis. Pandemics are common throughout human history and difficult to avoid or prevent; thus, we intend to encourage societies, academia, engineers and innovators to invest more in robots that cannot catch the virus and consequently introduce beneficial solutions to fight such pandemic in the future.


  • Open Access

    Potential Transcriptional Biomarkers to Guide Glucocorticoid Replacement in Autoimmune Addison’s Disease

    by Åse Bjorvatn Sævik, Anette B Wolff, Sigridur Björnsdottir, Katerina Simunkova, Martha Schei Hynne, David William Peter Dolan, Eirik Bratland, Per M Knappskog, Paal Methlie, Siri Carlsen, et al.

    Background No reliable biomarkers exist to guide glucocorticoid (GC) replacement treatment in autoimmune Addison’s disease (AAD), leading to overtreatment with alarming and persistent side effects or undertreatment, which could be fatal. Objective To explore changes in gene expression following different GC replacement doses as a means of identifying candidate transcriptional biomarkers to guide GC replacement in AAD. Methods Step 1: Global microarray expression analysis on RNA from whole blood before and after intravenous infusion of 100 mg hydrocortisone (HC) in 10 patients with AAD. In 3 of the most highly upregulated genes, we performed real-time PCR (rt-PCR) to compare gene expression levels before and 3, 4, and 6 hours after the HC infusion. Step 2: Rt-PCR to compare expression levels of 93 GC-regulated genes in normal versus very low morning cortisol levels in 27 patients with AAD. Results Step 1: Two hours after infusion of 100 mg HC, there was a marked increase in FKBP5, MMP9, and DSIPI expression levels. MMP9 and DSIPI expression levels correlated with serum cortisol. Step 2: Expression levels of CEBPB, DDIT4, FKBP5, DSIPI, and VDR were increased and levels of ADARB1, ARIDB5, and POU2F1 decreased in normal versus very low morning cortisol. Normal serum cortisol levels positively correlated with DSIPI, DDIT4, and FKBP5 expression. Conclusions We introduce gene expression as a novel approach to guide GC replacement in AAD. We suggest that gene expression of DSIPI, DDIT4, and FKBP5 are particularly promising candidate biomarkers of GC replacement, followed by MMP9, CEBPB, VDR, ADARB1, ARID5B, and POU2F1.


  • Application of Padlock and Selector Probes in Molecular Medicine

    by I. Hernández-Neuta, A. Mezger, L. Moens, C. Larsson, J. Stenberg, J. Göransson, I. Grundberg, M. Isaksson, T. Conze, S. Henriksson, et al.